Geoffrey Shouse, PhD, DO

Biography

Geoffrey Shouse, DO, PhD is an Assistant Professor in the Division of Lymphoma at City of Hope Comprehensive Cancer Center in Duarte, California, where he specializes in the treatment of patients with Hodgkin and non-Hodgkin lymphoma, including both aggressive and indolent B-cell malignancies. He earned his PhD in Cell, Molecular, and Developmental Biology from the University of California, Riverside, and his Doctor of Osteopathic Medicine degree from Western University of Health Sciences. He completed his internal medicine residency and hematology/oncology fellowship at Loma Linda University Medical Center, followed by fellowship training in Hematopoietic Cell Transplantation and Cellular Therapy at City of Hope. Dr. Shouse serves as a principal investigator on multiple clinical trials evaluating novel therapies for lymphoma, including CAR T-cell therapy, bispecific antibodies, targeted therapies, hematopoietic stem cell transplantation, and emerging immunotherapies. His research focuses on improving outcomes and expanding access to curative therapies for patients with lymphoma, with particular interests in cellular therapy, treatment of relapsed and refractory disease, cancer and aging, and the care of older adults with hematologic malignancies. He has authored numerous publications on lymphoma, cellular therapy outcomes, and novel therapeutic approaches, and is actively involved in national and international clinical research collaborations.